Despite the rising number of cases, experts emphasised caution in using antiviral drugs indiscriminately for hMPV.

TRN-157 is under clinical development by Theron Pharmaceuticals and currently in Phase I for Chronic Obstructive Pulmonary Disease (COPD).

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Council tenant Karen Barrett, 65, from Birmingham, said that she now has nowhere to sleep because of insects and is also ...